卒中后目标LDL<70 mg/dL患者中LDL胆固醇降低超过50%的研究
TST试验事后分析纳入2860例缺血性卒中或短暂性脑缺血发作伴动脉粥样硬化患者,随机分为LDL<70 mg/dL或100±10 mg/dL目标组。在<70 mg/dL目标组中,LDL较基线降低>50%者主要结局风险显著低于较高目标组(HR 0.61),而降低<50%者无显著降低(HR 0.96)。
要点
- 在<70 mg/dL目标组,LDL降低>50%者主要结局风险显著低于100±10 mg/dL目标组(HR 0.61)。
- 在<70 mg/dL目标组,LDL降低<50%者主要结局风险与较高目标组无显著差异(HR 0.96)。
- 作者认为LDL降低幅度与目标水平同样重要。
核心结论
- 在TST试验的事后分析中,以LDL胆固醇<70 mg/dL为目标较100±10 mg/dL降低主要结局风险,前提是LDL胆固醇较基线降低超过50%,提示降低幅度与目标水平同样重要。
研究设计与样本
- TST试验在法国和韩国61个中心于2010年3月至2018年12月进行,纳入近3个月内缺血性卒中或近15天内短暂性脑缺血发作且有脑血管或冠状动脉粥样硬化证据的患者,随机分配至LDL胆固醇<70 mg/dL或100±10 mg/dL目标组,必要时使用他汀和/或依折麦布。
- 本分析使用随访3.9年(四分位距2.1-6.8)期间重复LDL测量结果(中位数每例5次[2-6])。
主要发现
- 共纳入2860例患者,在较低目标组中,试验期间LDL胆固醇较基线降低>50%者基线LDL较高且达到的LDL较低,与降低<50%者相比分别为155±32和62 mg/dL versus 121±34和74 mg/dL,P均<0.001。
- 在<70 mg/dL目标组中,LDL降低>50%者主要结局较较高目标组显著降低(风险比0.61[95%CI 0.43-0.88];P=0.007),而LDL降低<50%者降低幅度很小(风险比0.96[95%CI 0.73-1.26];P=0.75)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether a strategy to target an LDL (low-density lipoprotein) cholesterol <70 mg/dL is more effective when LDL is reduced >50% from baseline rather than <50% from baseline has not been investigated. METHODS: The Treat Stroke to Target trial was conducted in France and South Korea in 61 sites between March 2010 and December 2018. Patients with ischemic stroke in the previous 3 months or transient ischemic attack within the previous 15 days and evidence of cerebrovascular or coronary artery atherosclerosis were randomly assigned to a target LDL cholesterol of <70 mg/dL or 100±10 mg/dL, using statin and/or ezetimibe as needed. We used the results of repeated LDL measurements (median, 5 [2-6] per patient) during 3.9 years (interquartile range, 2.1-6.8) of follow-up. The primary outcome was the composite of ischemic stroke, myocardial infarction, new symptoms requiring urgent coronary or carotid revascularization, and vascular death. Cox regression model including lipid-lowering therapy as a time-varying variable, after adjustment for randomization strategy, age, sex, index event (stroke or transient ischemic attack), and time since the index event. RESULTS: Among 2860 patients enrolled, patients in the lower target group who had >50% LDL cholesterol reduction from baseline during the trial had a higher baseline LDL cholesterol and a lower LDL cholesterol achieved as compared to patients who had <50% LDL cholesterol reduction (155±32 and 62 mg/dL versus 121±34 and 74 mg/dL, respectively, P<0.001 for both). In the <70 mg/dL target group, patients with >50% LDL reduction had a significant reduction in the primary outcome as compared to the higher target group (hazard ratio, 0.61 [95% CI, 0.43-0.88]; P=0.007) and patients with <50% LDL reduction from baseline had little reduction (hazard ratio, 0.96 [95% CI, 0.73-1.26]; P=0.75). CONCLUSIONS: In this post hoc analysis of the TST trial, targeting an LDL cholesterol of <70 mg/dL reduced the risk of primary outcome compared with 100±10 mg/dL provided LDL cholesterol reduction from baseline was superior to 50%, thereby suggesting that the magnitude of LDL cholesterol reduction was as important to consider as the target level to achieve. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01252875. URL: https://clinicaltrialsregister.eu; Unique identifier: EUDRACT2009-A01280-57.
引用
- Amarenco P, Lavallée PC, Kim JS, et al. More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke. Stroke. 2023. PMID: 37376989. doi:10.1161/STROKEAHA.123.042621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。